ATE551431T1 - Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires - Google Patents

Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires

Info

Publication number
ATE551431T1
ATE551431T1 AT02736798T AT02736798T ATE551431T1 AT E551431 T1 ATE551431 T1 AT E551431T1 AT 02736798 T AT02736798 T AT 02736798T AT 02736798 T AT02736798 T AT 02736798T AT E551431 T1 ATE551431 T1 AT E551431T1
Authority
AT
Austria
Prior art keywords
variable domain
cloning sequences
new method
gene repertoire
immunological
Prior art date
Application number
AT02736798T
Other languages
English (en)
Inventor
Henry Hongjun Ji
Original Assignee
Henry Hongjun Ji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry Hongjun Ji filed Critical Henry Hongjun Ji
Application granted granted Critical
Publication of ATE551431T1 publication Critical patent/ATE551431T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02736798T 2001-05-14 2002-05-14 Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires ATE551431T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29090701P 2001-05-14 2001-05-14
PCT/US2002/015125 WO2002092770A2 (en) 2001-05-14 2002-05-14 Novel method for cloning variable domain sequences of immunological gene repertoire

Publications (1)

Publication Number Publication Date
ATE551431T1 true ATE551431T1 (de) 2012-04-15

Family

ID=23117996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736798T ATE551431T1 (de) 2001-05-14 2002-05-14 Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires

Country Status (4)

Country Link
EP (1) EP1392866B1 (de)
AT (1) ATE551431T1 (de)
CA (1) CA2450217A1 (de)
WO (1) WO2002092770A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2877820T3 (es) * 2016-08-01 2021-11-17 Health Research Inc Composiciones y métodos para la clonación rápida de receptores de células T
US11001868B2 (en) * 2017-08-11 2021-05-11 Global Life Sciences Solutions Operations UK Ltd Cell-free protein expression using double-stranded concatameric DNA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512463A (en) * 1991-04-26 1996-04-30 Eli Lilly And Company Enzymatic inverse polymerase chain reaction library mutagenesis
US6107059A (en) * 1992-04-29 2000-08-22 Affymax Technologies N.V. Peptide library and screening method
EP0628076A1 (de) * 1992-11-19 1994-12-14 GINGERAS, Thomas R. Verwendung von rekombinante Monoklonale Antikörpern durch in Vitro Kulten von Milz-Bruchstücke in Verbindung mit der '3sR'RNA Amplifikations techniek
US5834252A (en) * 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
WO1995025180A1 (en) * 1994-03-16 1995-09-21 Gen-Probe Incorporated Isothermal strand displacement nucleic acid amplification
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
JP2002525049A (ja) * 1998-09-15 2002-08-13 イェール ユニバーシティ ローリングサークル増幅を用いる分子クローニング
WO2000075356A1 (en) * 1999-06-04 2000-12-14 Lin Shi Lung Rna polymerase chain reaction
WO2002048401A2 (en) * 2000-12-11 2002-06-20 Alexion Pharmaceuticals, Inc. Nested oligonucleotides containing hairpin for nucleic acid amplification

Also Published As

Publication number Publication date
EP1392866B1 (de) 2012-03-28
WO2002092770A2 (en) 2002-11-21
EP1392866A2 (de) 2004-03-03
EP1392866A4 (de) 2004-12-22
CA2450217A1 (en) 2002-11-21
WO2002092770A3 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
WO2022271884A3 (en) Methods and compositions relating to covid antibody epitopes
EP4283295A3 (de) Rekombinante polyklonale proteine und verfahren zur verwendung davon
WO2023076420A3 (en) Multispecific sars-cov-2 antibodies and methods of use
CR9969A (es) Anticuerpos anti-globulomero ab, porciones de union a antigeno de estos, hibridomas correspondientes, acidos nucleicos, vectores, celulas huesped, metodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos
DK0937140T3 (da) Antistofmolekyler, som interagerer specifikt med et målmolekyles aktive sted eller klöft
WO2005103083A3 (en) Anti-cd38 human antibodies and uses therefor
PL374311A1 (en) Methods for purifying protein
ATE449186T1 (de) Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung
CA2457636A1 (en) Antigen binding domains
JOP20230134A1 (ar) الأجسام المضادة متعددة المواصفات لها مواصفات il-4r و il-31
DE602005009856D1 (de) Verfahren zur reinigung von fsh
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
ATE546524T1 (de) Verfahren zur herstellung aktiver scfv-antikörper und bibliotheken dafür
EA200600459A1 (ru) Способ получения цитотоксических лимфоцитов
ATE489478T1 (de) Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation
ATE269900T1 (de) Verfahren zur molekularen evolution der antikörperfunktion
DE60210087D1 (de) Verfahren zur standzeitverlängerung eines hydro-oxidationskatalysators
ATE551431T1 (de) Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires
DE602006021324D1 (de) Verfahren zur herstellung stabiler b-lymphozyten
DE50302456D1 (de) Verfahren zur Herstellung von organomodifizierten Polysiloxanen unter Verwendung ionischer Flüssigkeiten
DE50307968D1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
DK1396501T3 (da) Antistoffer til identifikation og/eller isolering af mindst én cellepopulation, der er valgt fra gruppen omfattende haematopoietiske stamceller, neuronale stamceller, neuronale precursorceller, mesenchymale stamceller og mesenchymale precursorceller
ATE539085T1 (de) Verfahren zur isolierung von haptoglobin
MX2021014885A (es) Composiciones de anticuerpos anti-tnf, y métodos para el tratamiento de la artritis psoriásica.
ATE402948T1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält